• Applied Workflows with YC-1: Optimizing HIF-1α Inhibition in

  2026-06-02

  YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol empowers precise dissection of hypoxia and angiogenesis mechanisms in cancer biology. This guide details advanced protocols, troubleshooting, and translational insights, drawing from recent multi-omics breakthroughs and comparative analyses.

• Luminescent ATP Cell Viability Assay Kit I: Precision in Fer

  2026-06-02

  The Luminescent ATP Cell Viability Assay Kit I empowers researchers with ultra-sensitive, rapid viability detection—critical for dissecting complex cell death mechanisms such as ferroptosis. Its streamlined, no-wash workflow and broad dynamic range set a new benchmark for metabolic and cytotoxicity assays in cancer research.

• Guilu Erxian Glue Reduces Oxidative Damage via Keap1/Nrf2 in

  2026-06-01

  The referenced study demonstrates that Guilu Erxian glue (GLEXG), a traditional Chinese medicine, protects mouse GC-1 spermatogonial cells from oxidative damage by inhibiting autophagy through modulation of the Keap1/Nrf2 signaling pathway. The findings provide mechanistic insight into GLEXG's role in male infertility models and suggest new strategies for managing oxidative stress in reproductive cells.

• Cycloheximide in Translational Control: From Mechanism to As

  2026-06-01

  Explore how Cycloheximide, a premier protein biosynthesis inhibitor, enables advanced translational regulation and apoptosis research. This article delivers unique insights into assay optimization, referencing the latest findings and bridging mechanistic depth with practical guidance.

• EdU Imaging Kits (Cy5): Precision S-Phase Detection & Workfl

  2026-05-31

  EdU Imaging Kits (Cy5) empower researchers with a non-destructive, high-sensitivity approach to quantifying cell proliferation—outperforming BrdU-based assays in both workflow simplicity and data fidelity. Optimized for fluorescence microscopy and flow cytometry, these kits enable robust genotoxicity assessment and S-phase analysis with minimal background.

• Chlorpromazine in Hepatic Nanoparticle Research: Mechanistic

  2026-05-30

  Explore how chlorpromazine advances hepatic nanoparticle research and antipsychotic mechanisms. This in-depth article integrates primary research findings and APExBIO’s high-purity chlorpromazine to guide experimental design and interpretation.

• Chemical Induction of Lhx1 in Mouse ES Cells via DNMT Inhibi

  2026-05-29

  This study presents a refined in vitro protocol for differentiating mouse embryonic stem cells into spermatogonia-like cells with increased Lhx1 expression, a key marker of undifferentiated spermatogonial stem cells. The findings highlight the importance of a DNA methyltransferase inhibitor (RG108) as part of a chemical intervention, offering new strategies for modeling male germline development.

• Coumestrol Induces Ferroptosis in RA Synoviocytes via PMAIP1

  2026-05-29

  This study identifies Coumestrol as a potent inducer of ferroptosis in rheumatoid arthritis fibroblast-like synoviocytes by stabilizing mitochondrial PMAIP1 through TRIM3 inhibition. These insights provide a mechanistic basis for targeting synovial proliferation and inflammation in RA, advancing selective estrogen receptor modulator research.

• BATF2-ATF3 Axis Drives Mitochondrial Dysfunction in IVDD Pro

  2026-05-28

  This study delineates how the BATF2-ATF3 signaling axis promotes intervertebral disc degeneration (IVDD) by inducing mitochondrial dysfunction and increasing apoptosis in nucleus pulposus cells. The findings suggest that targeting BATF2-ATF3 interactions could offer new therapeutic strategies for IVDD.

• GluN2A/B Subunits Regulate Sensitization in TMJ Inflammatory

  2026-05-28

  The referenced study elucidates how GluN2A and GluN2B subunits of NMDA receptors differentially regulate connexin and pannexin signaling in the trigeminal ganglion during orofacial inflammatory allodynia associated with TMJ inflammation. These insights reveal new peripheral sensitization mechanisms and identify potential molecular targets for pain management.

• Exosomal Egr2 Regulates RNF8/DAPK1 Axis in Ischemic Stroke

  2026-05-27

  This study reveals how bone marrow-derived mesenchymal stem cell (BMSC) exosomes, enriched in Egr2, mitigate neuronal injury after ischemic stroke by modulating the RNF8/DAPK1 pathway. These findings clarify the mechanistic link between exosomal signaling, ubiquitination, and neuroprotection, with implications for targeted stroke therapies.

• Berberrubine Suppresses IL-8/MCP-1 in RPE Cells via NF-κB Mo

  2026-05-27

  This study demonstrates that berberrubine inhibits the expression of the chemokines IL-8 and MCP-1 in human retinal pigment epithelial (RPE) cells stimulated with pro-inflammatory cytokines. The findings clarify berberrubine’s mechanistic role involving NF-κB translocation and highlight potential pathways for anti-inflammatory intervention in ocular research.

• I-BET151 (GSK1210151A): BET Inhibition for Cancer Biology

  2026-05-26

  I-BET151 (GSK1210151A) is a selective BET bromodomain inhibitor with demonstrated efficacy in disrupting oncogenic transcription, supporting apoptosis and cell cycle arrest assays in cancer biology. The compound targets BRD2, BRD3, and BRD4, with quantifiable anti-tumor effects in preclinical models. This article details its molecular action, protocol integration, and verified experimental outcomes.

• Phosphatase Inhibitor Cocktail (2 Tubes, 100X): Practical Gu

  2026-05-26

  The Phosphatase Inhibitor Cocktail (2 Tubes, 100X) is designed to prevent unwanted dephosphorylation of proteins during sample handling, which is critical for accurate analysis in phosphorylation-sensitive assays such as immunoblotting, kinase activity measurements, and mass spectrometry. It is not suitable for diagnostic or clinical applications and should be used exclusively for research purposes where preservation of protein phosphorylation is required.

• Refining In Vitro Drug Response Analysis in Cancer Research

  2026-05-25

  Schwartz's dissertation introduces a nuanced framework for evaluating anti-cancer drugs by disentangling the effects on cell proliferation and cell death in vitro. This approach deepens mechanistic interpretation and supports more accurate translation from preclinical models to therapeutic development.

461 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page